Clinical trial

GlitazOne Treatment for Coronavirus HypoxiA, a Safety and Tolerability Open Label With Matching Cohort Pilot Study

NCT04473274

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2020-05-21

PhasePHASE4

Study timeline

Study start (actual)2020-05-21Date precision: day

Registry last updated2020-12-04

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Coronavirus Infectionunresolved

Diabetesunresolved

Interventions

PioglitazoneDRUG · verified · RxNorm: pioglitazone

Sponsors & collaborators

Samaritan Health Serviceslead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04473274 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.